Dosimetry developer Sicel Technologies of Morrisville, NC, has received clearance from the U.S. Food and Drug Administration (FDA) to begin marketing its DVS-HFT wireless implantable dosimeter.
The Dose Verification System (DVS) device measures radiation dose at a tumor site for use in treating breast and prostate cancer patients undergoing external-beam radiation therapy.
The DVS-HFT dosimeter is specifically calibrated for use with radiation therapy protocols that give patients higher single doses of radiation over a shorter period of time compared to conventional radiation therapy.
Related Reading
Sicel names Med-Tec as distributor, September 23, 2004
Copyright © 2009 AuntMinnie.com
